Gianluigi Giuliani1†Giancarlo Sborgia1†
Alfredo Niro2*†Fabio Castellana3
Luisa Lampignano3Pasquale Puzo1Angelo Pascale1Valentina Pastore1Rosa Buonamassa1Roberta Galati1Marco Bordinone1Flavio Cassano1
Arcangelo Clemente1
Luca Landini1
Giacomo Scotti1Marida Gaudiomonte1Antonella Guglielmi1
Roberto Semeraro1Michele Santoro1Giovanni Alessio1
Rodolfo Sardone3Francesco Boscia1- 1Department of Medical Science, Neuroscience and Sense Organs, Eye Clinic, University of Bari, Bari, Italy
- 2Eye Clinic, Hospital “SS Annunziata,” ASL Taranto, Taranto, Italy
- 3Unit of Research Methodology and Data Sciences for Population Health, “Salus in Apulia Study,” National Institute of Gastroenterology “Saverio de Bellis,” Research Hospital, Bari, Italy
Objective: To explore the linear association between inner retinal layers thickness and macular capillary density compared to variations of global cognition evaluated by psychometric measures in a cohort of Mediterranean subjects aged 65+ years.
Materials and methods: We performed a cross-sectional analysis of 574 participants aged 65 years+ drawn from a population-based Southern Italian study. All subjects underwent neurological evaluations, including global cognitive screening, the Mini-Mental State Examination (MMSE) and frontal assessment battery (FAB), together with an ophthalmic examination including optical coherence tomography (OCT) and OCT-Angiography. We assessed the average thickness of the ganglion cell complex (GCC) and the retinal nerve fiber layer (RNFL), the foveal avascular zone area, and vascular density (VD) of superficial (SVD) and deep (DVD) capillary plexi at the foveal and parafoveal area. Linear regression was applied to assess associations of ocular measurements with MMSE and FAB scores.
Results: In the linear regression model, foveal DVD (beta = 0.01, 95% CI:0.004–0.052), whole DVD (beta = 0.04, 95% CI:0.02–0.08), and whole SVD (beta = 0.04, 95% CI:0.02–0.07) showed a positive association with MMSE. In addition, foveal SVD (beta = 0.01, 95% CI:0.003–0.05) and whole SVD (beta = 0.03, 95% CI:0.004–0.08) were positively associated with the FAB score. We found no further significant association between the MMSE score or the FAB score and the average thickness of the GCC and RNFL, and FAZ area.
Conclusion: A direct linear association between the VD of the macular capillary plexi with global and frontal cognitive functions was observed in elderly subjects.
Introduction
As the world population ages, mild cognitive impairment (MCI) and dementia are taking on an ever growing social importance. Cognitive impairment is the most evident sign of all dementias including Alzheimer’s disease (AD), known to account for between 60 and 80% of all cases (Hebert et al., 2013). According to current knowledge, in the USA alone, 5.8 million people are affected by cognitive impairment and this figure is expected to rise to 13.8 million by 2050 (Hebert et al., 2013).
Aging and cardiovascular conditions have been suggested to drive chronic cerebral hypoperfusion (CCH) leading to neurodegenerative processes (Scheffer et al., 2021). Indeed, cerebral vascular and microvascular remodeling has been described in patients with cognitive impairment (Buée et al., 1994, 1997; Farkas and Luiten, 2001; O’Brien et al., 2003; Thompson and Hakim, 2009).
In recent decades, much of the research has been focused on recognizing biomarkers enabling diagnosis of the disease in the early stages (Shaw et al., 2007; Becker et al., 2008; Holtzman et al., 2011; Sperling et al., 2014). Indeed, neuropathological changes in the central nervous system are known to occur many years before the clinical onset of severe or MCI (Shaw et al., 2007; Becker et al., 2008; Holtzman et al., 2011; Sperling et al., 2014).
Embryologically, anatomically, and physiologically, the retina is an extension of the central nervous system and hence offers a privileged observational viewpoint (Byerly and Blackshaw, 2009; London et al., 2013; Trost et al., 2016; Vecino et al., 2016).
In this context, optical coherence tomography (OCT) scans previously confirmed thinning of the neuroretinal layers, including the ganglion cell complex (GCC) and, in particular, the retinal nerve fiber layer (RNFL), in AD (Chan et al., 2019) and MCI patients (Mejia-Vergara et al., 2020) as compared to age-matched control subjects. Also retinal microvascular changes, visualized non-invasively using fundoscopy or photographs of the retina, have been associated with cognitive decline and brain changes related to aging and vascular disease (Wong et al., 2002; Baker et al., 2007; Ding et al., 2008; Heringa et al., 2013). Optical coherence tomography angiography (OCT-A) is an innovative extension of OCT technology. It provides non-invasive depth-resolved visualization of the retinal microvasculature, using phase or amplitude decorrelation to identify the motion contrast of blood flow (Spaide et al., 2015; Kashani et al., 2017). It has been successfully used in several studies to explore the predictive power of retinal vessel features for neurodegenerative diseases (Bulut et al., 2018; O’Bryhim et al., 2018; Zhang et al., 2019), revealing a reduction of vascular density (VD) at the macula in patients with MCI and AD (Bulut et al., 2018; Jiang et al., 2018; Yoon et al., 2019).
Together with personal history, physical examination and laboratory tests, psychometric measures, such as the Mini-Mental State Examination (MMSE), Alzheimer’s disease assessment scale- (ADAS-Cog), clinical dementia rating (CDR) score, and frontal assessment battery (FAB), are used nowadays to test a range of everyday cognitive abilities that can reveal cognitive impairment.
In AD but not in MCI patients, multiple linear regression models showed a strong association between overall RNFL thickness and the MMSE score (Ascaso et al., 2014). Moreover, Shen et al. (2013) observed that RNFL thinning could have a predictive role in cognitive decline.
The aim of this study was to explore the linear association between inner retinal layers thinning and macular capillary density reductions and variations of global cognition measures, including the MMSE and FAB, in a cross-sectional study of Mediterranean subjects aged 65 + years.
Materials and methods
Participants were recruited from the Salus in Apulia Study, a population-based study on aging conducted on subjects aged over 65 years, resident in Castellana Grotte, a town located near Bari, Puglia in the South-east of Italy. The final sample frame was the Castellana Grotte electoral list on 31 December 2014, including 19,675 subjects, 4,008 aged 65 years or older. The Salus in Apulia Study has focused on the impact of nutrition, frailty, and age-related sensory impairments as predictors of common neurodegenerative and psychiatric diseases in older age. Detailed methodology of the original study is reported elsewhere (Tortelli et al., 2017). We collaborated with general practitioners who invited older subjects, previously selected with the support of the city census office, to participate in the study. Subjects enrolled in the SALUS study underwent several multi-specialist visits, including neurological and neuropsychological assessments and a complete ophthalmological evaluation. In particular, in this study we analyzed data on subjects who underwent OCT and OCT-A examinations. Prior approval of the study was obtained from the Institutional Review Board of the “National Institute of Gastroenterology “S. De Bellis” (Approval Code: 68/CE De Bellis; Approval Date: 9 April 2019). Written informed consent was obtained from all the participants in this study, all community-dwelling older adults.
The present study adhered to the “Standards for Reporting Diagnostic Accuracy Studies” (STARD) guidelines,1 the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) guidelines,2 and was conducted in accordance with the 1975 Declaration of Helsinki.
Ophthalmological assessment
Each participant underwent best-corrected visual acuity (BCVA) determination of each eye. BCVA was recorded as Snellen visual acuity and converted to the logarithm of minimal angle of resolution (LogMar) units for statistical analysis. Patients underwent slit-lamp biomicroscopy and intraocular pressure (IOP) measurement using a Goldmann-type applanation tonometer (Perkins MK2 Handheld Tonometer, Clement-Clarke Haag-Streit, Essex, UK). We performed funduscopy and then OCT and OCT-A using AngioVue OCT-Angiography (Optovue RTVue XR 100 AVANTI, Optovue, Inc., Fremont, CA, United States). The OCT-A machine captures two consecutive B-scans (M-B frame), each containing 304 A-scans with an A-scan rate of 70,000 scans per second, using a light source with a bandwidth of 45 nm centered on 840 nm. Split-spectrum amplitude-decorrelation angiography (SSADA) then extracts blood flow information by quantifying the decorrelation value, which represents differences in signal intensity between consecutive B-scans of the same location on the retina. OCT-A also analyzes the retinal structure, so multiple retinal layers can be identified and the vasculature in the corresponding layers can be segmented. OCT segmentation was performed using the AngioVue module with Optovue RTVue AVANTI software (version 2015.100.0.35, Optovue, Inc., Fremont, CA, United States). The mode was set at Angio Retina (3 mm× 3 mm) and Angio Disc (4.5 mm × 4.5 mm). RTvue software includes Optovue Motion Correction Technology (MCT) and 3D Projection Artifact Technology. The software provides the signal strength index (SSI), which represents the scan’s reflectance signal strength, and a quality index (Q-score), which represents the overall quality of the image, taking into account factors like SSI and motion artifacts (Kashani et al., 2017). In the present study, we only included images with a Q-score of 6 or above, an SSI above 70, and without motion or shadow artifacts. The examinations were performed blinded by trained ophthalmologists.
The vessel density (VD,%), defined as the percentage area occupied by the vessels in the corresponding region, was automatically measured by the built-in OCT device software.
The OCT angiograms centered on the fovea were automatically segmented to define the superficial plexus, from 3 μm below the internal limiting membrane to 15 μm below the inner plexiform layer (IPL), and the deep plexus, from 15 to 70 μm below the inner plexi-form layer. The VD at each macular plexus, and superficial VD (SVD) and deep VD (DVD), were calculated for the whole 3-mm circle area centered on the fovea (whole retina), for the area between the outer 3-mm circle and the inner 1-mm circle (parafoveal quadrant), and for the area inside the central 1-mm circle (foveal quadrant) (Figure 1).
Figure 1. Optical coherence tomography (OCT) angiographic images of the macular region and corresponding structural OCT scans. The macular vessel density measurement included measurements of the superficial (A) and deep vascular (B) plexi in an area measuring 3 mm× 3mm. The macular area was divided into a foveal and a parafoveal area between two concentric circles with a 1 and 3 mm diameter, respectively (A,B). The colored lines (red and green) in horizontal OCT B-scans show segmentation lines defining the different depths in the retinal tissue. The superficial capillary plexus is segmented from approximately 3 μm below the inner limiting membrane to 15 μm below the inner plexiform layer (IPL) (C). The deep capillary plexus is segmented from 15 μm below the IPL to 70 μm below the IPL (D).
Measurement of the foveal avascular zone (FAZ, mm2) at the deep capillary plexus (image in Supplementary Figure 1) was performed as described in detail elsewhere (Shahlaee et al., 2016).
The average thickness (μm) of the GCC, composed of the thickness of the RNFL, ganglion cell layer (GCL), and IPL, at the macular area, and, separately, of the RNFL, were measured at the same time using the same OCT system (image in Supplementary Figure 2).
Ocular exclusion criteria for all study participants included an IOP > 22 mmHg, a history of glaucoma, optic neuropathies, demyelinating disorders, retinal diseases including macular degeneration, diabetic or hypertensive retinopathy, epiretinal membrane, retinal detachment, an obvious media opacity reducing visual acuity below 1 LogMar and interfering with the OCT and OCT-A analysis, a refractive error of 6 diopters or more, an intraocular surgery performed in the previous 6 months or ocular trauma.
Data export was performed using the GreatAGEstudy App (Phronema srl, Bari, Italy), a software designed specifically to support the ancillary study of the Salus in Apulia Study, denominated the GreatAGE study.
Cognitive assessment
A licensed neurologist performed a standard neurological examination exploring perception, deambulation, cranial nerves, motor function (muscle tone, upright posture, and tropism), pathological gestures, sensory function, cerebellar and sphincter functions, deep tendon reflexes, and signs of diffuse cerebral distress.
Cognitive mental status was assessed with the MMSE, which consists of eleven questions, focused only on the global cognitive aspects of mental functions (Measso et al., 1993). The FAB is a brief, simple tool used to assess executive function (Dubois et al., 2000).
Statistical analysis
Continuous variables were expressed as mean ± standard deviation (SD) and categorical variables as proportion (%). Statistical significance was set at p-value < 0.05, with 95% confidence intervals (CI). The characteristics of the population in terms of distributions and frequencies, means with standard deviations (SD) and medians were calculated. Linear regression models were applied to assess associations, using SVD and DVD at foveal, parafoveal and whole retina levels, of increased thicknesses (expressed as percentages) of the ganglionar cellular complex (GCC) and retinal nerve fiber layers (RNFL) as independent variables, with MMSE and FAB scores. We built three hierarchical nested models: an unadjusted model, a partially adjusted model (adjusted for age, gender, and education) and a fully-adjusted model [adjusted for age, gender and education Diabetes, Hypertension, SSI (lower) and visual acuity]. To reduce selection bias and simplify the reading of results we used a complete randomization algorithm for the eye selection, assigning the corresponding value (left or right eye) to the new variable thus created.
Statistical analyses were performed with RStudio software, Version 1.2.1335 using additional packages: tidyverse, kable.
Results
From 2016 to 2019, 892 of the 1,929 participants in the Salus in Apulia Study underwent an ophthalmological examination including OCT and OCT-A scans. Of these, 318 subjects were excluded due to incomplete clinical evaluations, media opacity severely reducing visual acuity, macular diseases, glaucoma, hypertensive retinopathy, and erroneous scans including scans with segmentation failure. Overall, 574 older individuals (63% women) were eligible for the analysis presented in this study. Mean age of the whole sample was 73.82 ± 6.17 years. The average number of years of education was 6.94 ± 3.83 years. Mean MMSE and FAB scores were 26.16 ± 4.31 and 12.98 ± 3.82, respectively. All other sociodemographic and ophthalmological variables are reported in Table 1. Data of the whole Salus in Apulia sample are shown in Supplementary Table 1.
Table 1. Description of sociodemographic and variables of the whole sample. N:574.
In the linear regression partially adjusted model, corrected for age, gender, and education (Table 2), foveal DVD (beta = 0.069, CI 95% 0.001–0.139) and whole DVD (beta = 0.064, CI 95% 0.001–0.127) showed a positive association with MMSE. Foveal SVD (beta = 0.081, CI 95% 0.019–0.142) and whole SVD (beta = 0.066, CI 95% 0.009–0.124) were also positively associated with the cognitive score. In the fully-adjusted model, the association remained significant only for foveal DVD (beta = 0.01, CI 95% 0.004–0.052), whole DVD (beta = 0.04, CI 95% 0.02–0.08), and whole SVD (beta = 0.04, CI 95% 0.02–0.07).
Table 2. Linear regression model on Mini-Mental State Examination (MMSE) as dependent variable and regressors.
In addition, foveal SVD (beta = 0.01, CI 95% 0.003–0.05) and whole SVD (beta = 0.03, CI 95% 0.004–0.08) were positively associated with global cognitive function as assessed by the FAB (Table 3).
Table 3. Linear regression models on Frontal Assessment Battery (FAB) as dependent variable and regressor.
We found no further significant association between the MMSE score or between the FAB score and the average thickness of the GCC and RNFL, and FAZ area.
Discussion
In this large study of OCT-A findings in a Mediterranean population from Castellana Grotte aged over 65 years, we observed a direct linear association between the VD of the retinal capillary plexi, and global and frontal cognitive functions, measured with MMSE and FAB, respectively. A lower cognitive test score corresponded to a lower VD, particularly at the foveal site. The mechanism behind the retinal capillary density reduction in patients with cognitive impairment is not known. A reduction in the brain capillary density, both age-related (Bell and Ball, 1981; Vecino et al., 2016) and AD-related (Bell and Ball, 1981; Fischer et al., 1990; Buée et al., 1997; Vecino et al., 2016), has been demonstrated in several studies.
The anti-angiogenic activity of perivascular β-amyloid plaques accumulation has been proposed as a cause of capillary density reduction in patients with AD (Paris et al., 2004a,b). In particular, decreased angiogenesis, due to sequestration of vascular-endothelial growth factor (VEGF) in β-amyloid plaques and competitive binding of β-amyloid to VEGF receptor 2, has been proposed as the possible mechanism underlying cerebral VD reductions (Yang et al., 2004).
In addition, an age-related reduction in angiogenesis capacity was reported (Black et al., 1989; Rivard et al., 1999). With aging, the expression of hypoxia-inducible factor-1 (HIF-1) is reduced (Rivard et al., 2000; Chavez and LaManna, 2003). HIF-1 is the transcription factor leading to the synthesis of VEGF in hypoxia conditions (Saint-Geniez and D’Amore, 2004). The reduction in HIF-1 is associated with a reduction in VEGF and neuronal loss (Rapino et al., 2005). With aging in AD, therefore, vascular recovery from hypoxia is impaired.
Furthermore, direct β-amyloid endothelial damage, causing small vessels destruction, has also been noted (Li et al., 2020). Koronyo-Hamaoui et al. (2011) identified postmortem β-amyloid plaques in the retina of AD patients. In a histological study of patients with AD, β-amyloid plaques were found, associated with retinal blood vessels and located in the perivascular area (Koronyo et al., 2017). Although in the classical hypothesis β-amyloid plaques and neurofibrillary tangles are recognized as the main pathogenic mechanism, different studies have attributed an increasing importance to the various vascular alterations present in patients with AD and cognitive impairment (Cheung et al., 2014; Feke et al., 2015; Sweeney et al., 2019).
Chronic cerebral hypoperfusion induces a reduction of nutrients supply to the brain, causing direct damage not only to parenchymal cells but also to the vascular constituents of the blood-brain-barrier (BBB) (Sweeney et al., 2019). BBB dysfunction mediates the indirect neurotoxic effect by promoting oxidative stress, inflammation paracellular permeability, and dysregulation of nitric oxide, a key regulator of regional blood flow (Sweeney et al., 2019). All these events trigger a vicious circle in which cerebral perfusion is reduced and the neurodegenerative process is accelerated. Reciprocal interactions between vascular dysfunction and neurodegeneration could further contribute to the development of the disease (Sweeney et al., 2019). Thus, the previously observed (Bulut et al., 2018; Yoon et al., 2019; Chua et al., 2020; Criscuolo et al., 2020; Wu et al., 2020; Hui et al., 2021; Zhang et al., 2021) close link between microvascular alterations and cognitive impairment, also confirmed by our results, shows that retinal VD may be an ocular biomarker of age-related neurocognitive disease.
Conversely, we did not find any association between GCC and RNFL thickness and MMSE and FAB scores. Several studies have revealed thinning of RNFL in MCI and AD patients as compared to controls (Berisha et al., 2007; Paquet et al., 2007; Kesler et al., 2011), and a linear association between RNFL volume reduction and neocortical Aβ accumulation, after controlling for normal aging (Santos et al., 2018).
However, it should be considered that RNFL thickness in healthy old adults is extremely heterogeneous (Poinoosawmy et al., 1997; Parikh et al., 2007). While some studies were unable to find differences in retinal layers thickness between MCI patients and controls (Cheung et al., 2015; Feke et al., 2015; Pillai et al., 2016; Golzan et al., 2017; Kwon et al., 2017), others found equal values of RNFL thickness between MCI patients and healthy subjects (Oktem et al., 2015; Ferrari et al., 2017). Furthermore, thinning of the RNFL is also present in other types of dementia, such as frontotemporal dementia (Ferrari et al., 2017), dementia with Lewy bodies, dementia associated with Parkinson’s disease (Moreno-Ramos et al., 2013) and with cerebral autosomal dominant arteriopathy with subcortical infarcts and leuco-encephalopathy (CADASIL) (Parisi et al., 2007), challenging the specificity of OCT findings in cognitive impairment.
The strength of this study lies in the large number of subjects analyzed. We also adjusted for age, gender, and education during analysis, and had excluded confounding factors such as diabetes, ocular disease, and media opacity reducing visual acuity so much to interfere with OCT image acquisition and analysis. Furthermore, the measurements of one eye were randomly adopted for each subject as a good practice for statistical analysis (Armstrong, 2013).
A limitation of the study is that we did not evaluate the axial length of the eyes analyzed with OCT-A. Extreme axial length can cause an alteration in the retinal VD calculation (Yang et al., 2016). However, the large study population and the exclusion of patients with extreme refractive defects should have reduced this possible bias.
A methodology limit of the present study is the cross-sectional nature of the data, preventing assessment of the direction of the association, and introducing a high risk of reverse causality bias. An important methodological point is that clearly, we could not adjust for differences in prior cognitive ability when analyzing the association between retinal parameters and cognitive ability later in life. Childhood cognitive ability accounts for a large proportion of variance in cognitive ability in old age (Deary et al., 2004). Differences in prior cognitive ability are associated with health, morbidity and mortality outcomes, including those related to cerebrovascular disease (Gottfredson and Deary, 2004; Deary et al., 2010). Hence, the cross-sectional association between retinal vascular measures and cognitive ability reported in this study could inevitably be confounded by prior cognitive ability. Lastly, with did not correct the models for cardiovascular and cerebrovascular diseases due to the lack of these data.
In conclusion, the present findings confirmed the association between impaired cognitive test scores and retinal VD in older subjects, suggesting that this may be a potential ocular biomarker of age related-neurocognitive disease and confirming the OCT-A as a non-invasive tool to identify this biomarker in preclinical stages of cognitive impairment. Further larger studies, in longitudinal cohorts or with a randomized clinical trial design, are needed to test the effectiveness of applying retinal capillary density as a novel biomarker to predict the incidence and progression of cognitive impairment, also at population level.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving human participants were reviewed and approved by Institutional Review Board of the “National Institute of Gastroenterology “S. De Bellis” (Approval Code: 68/CE De Bellis; Approval Date: April 9, 2019). The patients/participants provided their written informed consent to participate in this study.
Author contributions
GG and GSb: conceptualization. GG, AN, PP, AP, VP, RB, RG, MB, FCass, AC, LLan, GSc, MG, AG, RSe, and MS: data curation. FCast: formal analysis. RSa: funding acquisition and project administration. GG and AN: investigation. GG, AN, and RSa: methodology. GG, GSb, and AN: resources. GSb and RSa: supervision. GG and AN: writing – original draft preparation. GA, RSa, LLam, and FB: writing – review and editing. All authors have read and agreed to the published version of the manuscript.
Acknowledgments
We thank the “Salus in Apulia” Research Team. This manuscript is the result of the research work on frailty undertaken by the “Research Network on Aging” team, supported by the resources of the Italian Ministry of Health—Research Networks of National Health Institutes. We thank M. V. Pragnell, BA, for her precious help as native English supervisor. We also thank the General Practitioners of Castellana Grotte, for their fundamental role in the recruitment of participants to these studies: Cecilia Olga Maria Campanella, Annamaria Daddabbo, Giosuè Dell’aera, Rosalia Francesca Giustiniano, Massimo Guzzoni Iudice, Savino Lomuscio, Rocco Lucarelli, Antonio Mazzarisi, Mariana Palumbo, Maria Teresa Persio, Rosa Vincenza Pesce, Gabriella Puzzovivo, Pasqua Maria Romano, Cinzia Sgobba, Francesco Simeone, Paola Tartaglia, and Nicola Tauro.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2022.999796/full#supplementary-material
Footnotes
References
Armstrong, R. A. (2013). Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol. Opt. 33, 7–14. doi: 10.1111/opo.12009
Ascaso, F. J., Cruz, N., Modrego, P. J., Lopez-Anton, R., Santabárbara, J., Pascual, L. F., et al. (2014). Retinal alterations in mild cognitive impairment and Alzheimer’s disease: An optical coherence tomography study. J. Neurol. 261, 1522–1530. doi: 10.1007/s00415-014-7374-z
Baker, M. L., Marino Larsen, E. K., Kuller, L. H., Klein, R., Klein, B. E. K., Siscovick, D. S., et al. (2007). Retinal microvascular signs, cognitive function, and dementia in older persons: The Cardiovascular Health Study. Stroke 38, 2041–2047. doi: 10.1161/STROKEAHA.107.483586
Becker, R. E., Greig, N. H., and Giacobini, E. (2008). Why do so many drugs for Alzheimer’s disease fail in development? Time for new methods and new practices? J. Alzheimers Dis. 15, 303–325. doi: 10.3233/jad-2008-15213
Bell, M. A., and Ball, M. J. (1981). Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol. 53, 299–318. doi: 10.1007/bf00690372
Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., and Schepens, C. L. (2007). Retinal abnormalities in early Alzheimer’s disease. Invest. Ophthalmol. Vis. Sci. 48, 2285–2289. doi: 10.1167/iovs.06-1029
Black, J. E., Polinsky, M., and Greenough, W. T. (1989). Progressive failure of cerebral angiogenesis supporting neural plasticity in aging rats. Neurobiol. Aging 10, 353–358. doi: 10.1016/0197-4580(89)90048-1
Buée, L., Hof, P. R., and Delacourte, A. (1997). Brain microvascular changes in Alzheimer’s disease and other dementias. Ann. N. Y. Acad. Sci. 826, 7–24. doi: 10.1111/j.1749-6632.1997.tb48457.x
Buée, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., et al. (1994). Pathological alterations of the cerebral microvasculature in Alzheimer’s disease and related dementing disorders. Acta Neuropathol. 87, 469–480. doi: 10.1007/bf00294173
Bulut, M., Kurtuluş, F., Gözkaya, O., Erol, M. K., Cengiz, A., Akıdan, M., et al. (2018). Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia. Br. J. Ophthalmol. 102, 233–237. doi: 10.1136/bjophthalmol-2017-310476
Byerly, M. S., and Blackshaw, S. (2009). Vertebrate retina and hypothalamus development. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 380–389. doi: 10.1002/wsbm.22
Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., et al. (2019). Spectral-domain OCT measurements in Alzheimer’s disease: A systematic review and meta-analysis. Ophthalmology 126, 497–510. doi: 10.1016/j.ophtha.2018.08.009
Chavez, J. C., and LaManna, J. C. (2003). Hypoxia-inducible factor-1alpha accumulation in the rat brain in response to hypoxia and ischemia is attenuated during aging. Adv. Exp. Med. Biol. 510, 337–341. doi: 10.1007/978-1-4615-0205-0_55
Cheung, C. Y.-L., Ong, Y. T., Hilal, S., Ikram, M. K., Low, S., Ong, Y. L., et al. (2015). Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J. Alzheimers Dis. 45, 45–56. doi: 10.3233/JAD-141659
Cheung, C. Y.-L., Ong, Y. T., Ikram, M. K., Ong, S. Y., Li, X., Hilal, S., et al. (2014). Microvascular network alterations in the retina of patients with Alzheimer’s disease. Alzheimers Dement. 10, 135–142. doi: 10.1016/j.jalz.2013.06.009
Chua, J., Hu, Q., Ke, M., Tan, B., Hong, J., Yao, X., et al. (2020). Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment. Alzheimers Res. Ther. 12:161. doi: 10.1186/s13195-020-00724-0
Criscuolo, C., Cennamo, G., Montorio, D., Carotenuto, A., Strianese, A., Salvatore, E., et al. (2020). Assessment of retinal vascular network in amnestic mild cognitive impairment by optical coherence tomography angiography. PLoS One 15:e0233975. doi: 10.1371/journal.pone.0233975
Deary, I. J., Weiss, A., and Batty, G. D. (2010). Intelligence and personality as predictors of illness and death: How researchers in differential psychology and chronic disease epidemiology are collaborating to understand and address health inequalities. Psychol. Sci. Public Interest 11, 53–79. doi: 10.1177/1529100610387081
Deary, I. J., Whiteman, M. C., Starr, J. M., Whalley, L. J., and Fox, H. C. (2004). The impact of childhood intelligence on later life: Following up the Scottish mental surveys of 1932 and 1947. J. Pers. Soc. Psychol. 86, 130–147. doi: 10.1037/0022-3514.86.1.130
Ding, J., Patton, N., Deary, I. J., Strachan, M. W. J., Fowkes, F. G. R., Mitchell, R. J., et al. (2008). Retinal microvascular abnormalities and cognitive dysfunction: A systematic review. Br. J. Ophthalmol. 92, 1017–1025. doi: 10.1136/bjo.2008.141994
Dubois, B., Slachevsky, A., Litvan, I., and Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology 55, 1621–1626. doi: 10.1212/wnl.55.11.1621
Farkas, E., and Luiten, P. G. (2001). Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog. Neurobiol. 64, 575–611. doi: 10.1016/s0301-0082(00)00068-x
Feke, G. T., Hyman, B. T., Stern, R. A., and Pasquale, L. R. (2015). Retinal blood flow in mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement. 1, 144–151.
Ferrari, L., Huang, S.-C., Magnani, G., Ambrosi, A., Comi, G., and Leocani, L. (2017). Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer’s disease. J. Alzheimers Dis. 56, 1101–1107. doi: 10.3233/JAD-160886
Fischer, V. W., Siddiqi, A., and Yusufaly, Y. (1990). Altered angioarchitecture in selected areas of brains with Alzheimer’s disease. Acta Neuropathol. 79, 672–679. doi: 10.1007/bf00294246
Golzan, S. M., Goozee, K., Georgevsky, D., Avolio, A., Chatterjee, P., Shen, K., et al. (2017). Retinal vascular and structural changes are associated with amyloid burden in the elderly: Ophthalmic biomarkers of preclinical Alzheimer’s disease. Alzheimers Res. Ther. 9:13. doi: 10.1186/s13195-017-0239-9
Gottfredson, L. S., and Deary, I. J. (2004). Intelligence predicts health and longevity, but why? Curr. Dir. Psychol. Sci. 13, 1–4. doi: 10.1111/j.0963-7214.2004.01301001.x
Hebert, L. E., Weuve, J., Scherr, P. A., and Evans, D. A. (2013). Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778–1783. doi: 10.1212/WNL.0b013e31828726f5
Heringa, S. M., Bouvy, W. H., van den Berg, E., Moll, A. C., Kappelle, L. J., and Biessels, G. J. (2013). Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: A systematic review. J. Cereb. Blood Flow Metab. 33, 983–995. doi: 10.1038/jcbfm.2013.58
Holtzman, D. M., Morris, J. C., and Goate, A. M. (2011). Alzheimer’s disease: The challenge of the second century. Sci. Transl. Med. 3:77sr1. doi: 10.1126/scitranslmed.3002369
Hui, J., Zhao, Y., Yu, S., Liu, J., Chiu, K., and Wang, Y. (2021). Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer’s disease patients: A meta-analysis. PLoS One 16:e0255362. doi: 10.1371/journal.pone.0255362
Jiang, H., Wei, Y., Shi, Y., Wright, C. B., Sun, X., Gregori, G., et al. (2018). Altered macular microvasculature in mild cognitive impairment and Alzheimer disease. J. Neuro Ophthalmol. 38, 292–298. doi: 10.1097/wno.0000000000000580
Kashani, A. H., Chen, C.-L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., et al. (2017). Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog. Retin. Eye Res. 60, 66–100. doi: 10.1016/j.preteyeres.2017.07.002
Kesler, A., Vakhapova, V., Korczyn, A. D., Naftaliev, E., and Neudorfer, M. (2011). Retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Clin. Neurol. Neurosurg. 113, 523–526. doi: 10.1016/j.clineuro.2011.02.014
Koronyo, Y., Biggs, D., Barron, E., Boyer, D. S., Pearlman, J. A., Au, W. J., et al. (2017). Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease. JCI Insight 2:e93621. doi: 10.1172/jci.insight.93621
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., et al. (2011). Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl. 1), S204–S217. doi: 10.1016/j.neuroimage.2010.06.020
Kwon, J. Y., Yang, J. H., Han, J. S., and Kim, D. G. (2017). Analysis of the retinal nerve fiber layer thickness in Alzheimer disease and mild cognitive impairment. Korean J. Ophthalmol. 31:548. doi: 10.3341/kjo.2016.0118
Li, T., Huang, Y., Cai, W., Chen, X., Men, X., Lu, T., et al. (2020). Age-related cerebral small vessel disease and inflammaging. Cell Death Dis. 11:932. doi: 10.1038/s41419-020-03137-x
London, A., Benhar, I., and Schwartz, M. (2013). The retina as a window to the brain-from eye research to CNS disorders. Nat. Rev. Neurol. 9, 44–53. doi: 10.1038/nrneurol.2012.227
Measso, G., Cavarzeran, F., Zappalà, G., Lebowitz, B. D., Crook, T. H., Pirozzolo, F. J., et al. (1993). The mini−mental state examination: Normative study of an Italian random sample. Dev. Neuropsychol. 9, 77–85. doi: 10.1080/87565649109540545
Mejia-Vergara, A. J., Restrepo-Jimenez, P., and Pelak, V. S. (2020). Optical coherence tomography in mild cognitive impairment: A systematic review and meta-analysis. Front. Neurol. 11:578698. doi: 10.3389/fneur.2020.578698
Moreno-Ramos, T., Benito-León, J., Villarejo, A., and Bermejo-Pareja, F. (2013). Retinal nerve fiber layer thinning in dementia associated with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. J. Alzheimers. Dis. 34, 659–664. doi: 10.3233/JAD-121975
O’Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., et al. (2003). Vascular cognitive impairment. Lancet Neurol. 2, 89–98. doi: 10.1016/s1474-4422(03)00305-3
O’Bryhim, B. E., Apte, R. S., Kung, N., Coble, D., and Van Stavern, G. P. (2018). Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 136, 1242–1248. doi: 10.1001/jamaophthalmol.2018.3556
Oktem, E. O., Derle, E., Kibaroglu, S., Oktem, C., Akkoyun, I., and Can, U. (2015). The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol. Sci. 36, 1141–1146. doi: 10.1007/s10072-014-2055-3
Paquet, C., Boissonnot, M., Roger, F., Dighiero, P., Gil, R., and Hugon, J. (2007). Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Neurosci. Lett. 420, 97–99. doi: 10.1016/j.neulet.2007.02.090
Parikh, R. S., Parikh, S. R., Sekhar, G. C., Prabakaran, S., Babu, J. G., and Thomas, R. (2007). Normal age-related decay of retinal nerve fiber layer thickness. Ophthalmology 114, 921–926. doi: 10.1016/j.ophtha.2007.01.023
Paris, D., Patel, N., DelleDonne, A., Quadros, A., Smeed, R., and Mullan, M. (2004a). Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci. Lett. 366, 80–85. doi: 10.1016/j.neulet.2004.05.017
Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., et al. (2004b). Inhibition of angiogenesis by Abeta peptides. Angiogenesis 7, 75–85. doi: 10.1023/B:AGEN.0000037335.17717.bf
Parisi, V., Pierelli, F., Coppola, G., Restuccia, R., Ferrazzoli, D., Scassa, C., et al. (2007). Reduction of optic nerve fiber layer thickness in CADASIL. Eur. J. Neurol. 14, 627–631. doi: 10.1111/j.1468-1331.2007.01795.x
Pillai, J. A., Bermel, R., Bonner-Jackson, A., Rae-Grant, A., Fernandez, H., Bena, J., et al. (2016). Retinal nerve fiber layer thinning in Alzheimer’s disease: A case-control study in comparison to normal aging, Parkinson’s disease, and non-Alzheimer’s dementia. Am. J. Alzheimers. Dis. Other Demen. 31, 430–436. doi: 10.1177/1533317515628053
Poinoosawmy, D., Fontana, L., Wu, J. X., Fitzke, F. W., and Hitchings, R. A. (1997). Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry. Br. J. Ophthalmol. 81, 350–354. doi: 10.1136/bjo.81.5.350
Rapino, C., Bianchi, G., Di Giulio, C., Centurione, L., Cacchio, M., Antonucci, A., et al. (2005). HIF-1alpha cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Aging Cell 4, 177–185. doi: 10.1111/j.1474-9726.2005.00161.x
Rivard, A., Berthou-Soulie, L., Principe, N., Kearney, M., Curry, C., Branellec, D., et al. (2000). Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J. Biol. Chem. 275, 29643–29647. doi: 10.1074/jbc.M001029200
Rivard, A., Fabre, J. E., Silver, M., Chen, D., Murohara, T., Kearney, M., et al. (1999). Age-dependent impairment of angiogenesis. Circulation 99, 111–120. doi: 10.1161/01.cir.99.1.111
Saint-Geniez, M., and D’Amore, P. A. (2004). Development and pathology of the hyaloid, choroidal and retinal vasculature. Int. J. Dev. Biol. 48, 1045–1058. doi: 10.1387/ijdb.041895ms
Santos, C. Y., Johnson, L. N., Sinoff, S. E., Festa, E. K., Heindel, W. C., and Snyder, P. J. (2018). Change in retinal structural anatomy during the preclinical stage of Alzheimer’s disease. Alzheimers Dement. (Amst.) 10, 196–209. doi: 10.1016/j.dadm.2018.01.003
Scheffer, S., Hermkens, D., Van Der Weerd, L., De Vries, H. E., and Daemen, M. (2021). Arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 41, 1265–1283.
Shahlaee, A., Pefkianaki, M., Hsu, J., and Ho, A. C. (2016). Measurement of foveal avascular zone dimensions and its reliability in healthy eyes using optical coherence tomography angiography. Am. J. Ophthalmol. 161, 50–55.e1. doi: 10.1016/j.ajo.2015.09.026
Shaw, L. M., Korecka, M., Clark, C. M., Lee, V. M.-Y., and Trojanowski, J. Q. (2007). Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat. Rev. Drug Discov. 6, 295–303. doi: 10.1038/nrd2176
Shen, Y., Shi, Z., Jia, R., Zhu, Y., Cheng, Y., Feng, W., et al. (2013). The attenuation of retinal nerve fiber layer thickness and cognitive deterioration. Front. Cell. Neurosci. 7:142. doi: 10.3389/fncel.2013.00142
Spaide, R. F., Klancnik, J. M. Jr., and Cooney, M. J. (2015). Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 133, 45–50. doi: 10.1001/jamaophthalmol.2014.3616
Sperling, R. A., Rentz, D. M., Johnson, K. A., Karlawish, J., Donohue, M., Salmon, D. P., et al. (2014). The A4 study: Stopping AD before symptoms begin? Sci. Transl. Med. 6:228fs13. doi: 10.1126/scitranslmed.3007941
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., et al. (2019). Vascular dysfunction-the disregarded partner of Alzheimer’s disease. Alzheimers Dement. 15, 158–167. doi: 10.1016/j.jalz.2018.07.222
Thompson, C. S., and Hakim, A. M. (2009). Living beyond our physiological means: Small vessel disease of the brainis an expression of a systemic failure in arteriolar function: A unifying hypothesis. Stroke 40, e322–e330. doi: 10.1161/STROKEAHA.108.542266
Tortelli, R., Lozupone, M., Guerra, V., Barulli, M. R., Imbimbo, B. P., Capozzo, R., et al. (2017). Midlife metabolic profile and the risk of late-life cognitive decline. J. Alzheimers Dis. 59, 121–130. doi: 10.3233/JAD-170153
Trost, A., Lange, S., Schroedl, F., Bruckner, D., Motloch, K. A., Bogner, B., et al. (2016). Brain and retinal pericytes: Origin, function and role. Front. Cell. Neurosci. 10:20. doi: 10.3389/fncel.2016.00020
Vecino, E., Rodriguez, F. D., Ruzafa, N., Pereiro, X., and Sharma, S. C. (2016). Glia-neuron interactions in the mammalian retina. Prog. Retin. Eye Res. 51, 1–40. doi: 10.1016/j.preteyeres.2015.06.003
Wong, T. Y., Klein, R., Sharrett, A. R., Nieto, F. J., Boland, L. L., Couper, D. J., et al. (2002). Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: The Atherosclerosis Risk in Communities Study. Stroke 33, 1487–1492. doi: 10.1161/01.str.0000016789.56668.43
Wu, J., Zhang, X., Azhati, G., Li, T., Xu, G., and Liu, F. (2020). Retinal microvascular attenuation in mental cognitive impairment and Alzheimer’s disease by optical coherence tomography angiography. Acta Ophthalmol. 98, e781–e787. doi: 10.1111/aos.14381
Yang, S.-P., Bae, D.-G., Kang, H. J., Gwag, B. J., Gho, Y. S., and Chae, C.-B. (2004). Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer’s disease. Neurobiol. Aging 25, 283–290. doi: 10.1016/s0197-4580(03)00111-8
Yang, Y., Wang, J., Jiang, H., Yang, X., Feng, L., Hu, L., et al. (2016). Retinal microvasculature alteration in high myopia. Invest. Ophthalmol. Vis. Sci. 57, 6020–6030. doi: 10.1167/iovs.16-19542
Yoon, S. P., Grewal, D. S., Thompson, A. C., Polascik, B. W., Dunn, C., Burke, J. R., et al. (2019). Retinal microvascular and neurodegenerative changes in Alzheimer’s disease and mild cognitive impairment compared with control participants. Ophthalmol. Retina 3, 489–499. doi: 10.1016/j.oret.2019.02.002
Zhang, Y. S., Zhou, N., Knoll, B. M., Samra, S., Ward, M. R., Weintraub, S., et al. (2019). Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer’s Disease on optical coherence tomography angiography. PLoS One 14:e0214685. doi: 10.1371/journal.pone.0214685
Keywords: retina, imaging, older (diseased) population, cognitive function, vessel density
Citation: Giuliani G, Sborgia G, Niro A, Castellana F, Lampignano L, Puzo P, Pascale A, Pastore V, Buonamassa R, Galati R, Bordinone M, Cassano F, Clemente A, Landini L, Scotti G, Gaudiomonte M, Guglielmi A, Semeraro R, Santoro M, Alessio G, Sardone R and Boscia F (2022) Correlation between retinal vessel rarefaction and psychometric measures in an older Southern Italian population. Front. Aging Neurosci. 14:999796. doi: 10.3389/fnagi.2022.999796
Received: 21 July 2022; Accepted: 06 September 2022;
Published: 23 September 2022.
Edited by:
Allison B. Reiss, New York University, United StatesReviewed by:
Zhongjing Lin, Shanghai Jiao Tong University, ChinaSteven H. Rauchman, University Neurosciences Institute, United States
Copyright © 2022 Giuliani, Sborgia, Niro, Castellana, Lampignano, Puzo, Pascale, Pastore, Buonamassa, Galati, Bordinone, Cassano, Clemente, Landini, Scotti, Gaudiomonte, Guglielmi, Semeraro, Santoro, Alessio, Sardone and Boscia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alfredo Niro, alfred.nir@tiscali.it
†These authors have contributed equally to this work